Saturday 17 October 2026
Export OABI’s income statement to Excel — free account
OmniAb, Inc.
OABI Healthcare Biotechnology
OmniAb, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $18.7 million, down 29.3% from fiscal 2024. In the quarter to June 2026, revenue grew 244.2%, EPS grew 66.7% and free cash flow grew 211.2%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
4.59
0.14
−2.96%
Follow OABI
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
5 | 5 | 2 | 4 |
+8 more TTM periods Free account |
| (16.95%) | (20.25%) | (23.36%) | (22.37%) | ||
| (15.11%) | (18.10%) | (20.68%) | (19.86%) | ||
ROIC |
(14.52%) | (16.96%) | (20.24%) | (19.81%) | |
Return on Tangible Assets |
(72.90%) | (89.61%) | (110.70%) | (95.95%) | |
Average Days of Receivables |
98.02 | 159.41 | 144.51 | 53.55 | |
Free Cash Flow per Share |
(0.14) | (0.18) | (0.30) | (0.28) | |
Free Cash Flow |
(18.14) | (23.02) | (34.02) | (32.25) | |
Capital Expenditures |
(0.47) | 2.48 | 2.44 | 2.40 | |
| Other line items | |||||
Cash ROIC |
(5.81%) | (7.38%) | (10.60%) | (9.57%) | |
Accounts Receivable Turnover |
5.90 | 3.03 | 2.95 | 6.40 | |
Accounts Payable Turnover |
0.33 | 0.18 | 0.15 | 2.51 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
1,149.50 | 1,914.22 | 2,263.48 | 135.54 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
(0.03) | (0.02) | (0.02) | (0.05) | |
Research and Development Expense of Revenue |
113.15% | 154.78% | 255.83% | 223.53% | |
Selling, General and Administrative Expense of Revenue |
69.92% | 96.48% | 156.51% | 140.97% | |
Share Based Compensation of Revenue |
36.58% | 51.90% | 84.77% | 82.18% | |
Operating CF/Net income |
0.40 | 0.47 | 0.56 | 0.54 | |
Depreciation/Fixed assets |
2.72 | 2.59 | 2.22 | 1.57 | |
Capex/Depreciation |
(0.02) | 0.11 | 0.12 | 0.12 | |
Revenue per Share |
0.30 | 0.23 | 0.16 | 0.18 | |
Operating CF per Share |
(0.14) | (0.20) | (0.32) | (0.30) | |
Capex per Share |
0.00 | 0.02 | 0.02 | 0.02 | |
Capex to Sales |
0.01 | (0.09) | (0.13) | (0.11) |
Columns are period end dates